Active, Not Recruiting
SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)
NCT04079166
- Conditions
- Malignant Melanoma, Melanoma, Melanoma (Skin), +13 more
- Locations
-
- Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
- Velindre University NHS Trust Cardiff, United Kingdom
- The Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
- Guy's & St Thomas' NHS Foundation Trust London, United Kingdom